Search | IOVS | ARVO Journals

Showing 1 – 20 of 49

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Intraocular pressure, optic nerve appearance, and posterior pole pathology in a large cohort of free-ranging rhesus macaques

Amanda Dawn Melin; Arturo Osvaldo Barron Arrambide; Rachel Munds; Michael Montague; John Danias; Gadi Wollstein; James Paul HIgham

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4784. doi:

ARVO Annual Meeting Abstract June 2020

3D Human Trabecular Meshwork model as a potential tool for gene screening

Karen Y Torrejon; Cula N Dautriche; Andrea Unser; Mathew Kerr; Feryan Ahmed; Abbey Van Alstyne-Ponce; Dan Stamer; Susan T Sharfstein; Yubing Xie; John Danias

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3441. doi:

ARVO Annual Meeting Abstract June 2020

Tissue plasminogen activator (tPA) in outflow facility regulation

Arturo Osvaldo Barron Arrambide; Sofya Gindina; Yan Hu; John Danias

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3452. doi:

ARVO Annual Meeting Abstract June 2020

Tissue plasminogen activator (tPA) rescues steroid-induced outflow facility reduction via non-enzymatic action

Sofya Gindina; Arturo Osvaldo Barron Arrambide; Yan Hu; John Danias

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1435. doi:

Glaucoma April 2019

Investigations on the Role of the Fibrinolytic Pathway on Outflow Facility Regulation

PDF

Yan Hu; Arturo O. Barron; Sofya Gindina; Sandeep Kumar; Shravan Chintala; Ashima Nayyar; John Danias
TAGS: alteplase, mice, platelet count measurement, urokinase, fibrinolysis pathway, regulation, gelatinase b
Invest. Ophthalmol. Vis. Sci.. 2019; 60(5):1571-1580. doi: https://doi.org/10.1167/iovs.18-25698

ARVO Annual Meeting Abstract July 2018

Stem Cell-Derived Schlemm’s Canal-like Cells for in vitro Glaucoma Drug Screening

Yangzi Isabel Tian; Karen Torrejon; John Danias; Yiqin Du; Yubing Xie

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3538. doi:

ARVO Annual Meeting Abstract June 2017

Human microvascular endothelial cells (HMVECs) assume Schlemm’s canal (HSC) cell characteristics after co-culture with human trabecular meshwork (HTM) cells and can be used to model conventional outflow

Karen Y Torrejon; Ellen Papke; Dhruba J Bharali; Magnus Bergkvist; W Daniel Stamer; Susan T Sharfstein; Yubing Xie; Feryan Ahmed; John Danias

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3471. doi:

ARVO Annual Meeting Abstract June 2017

Association between periodontal disease and primary open angle glaucoma

Konstantin Astafurov; Brian Ibabao; Leslie Hyman; John Danias

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2117. doi:

ARVO Annual Meeting Abstract June 2015

Differential effects of C1q ablation on glaucomatous damage in the two sexes in DBA/2 mice.

Ruma Kumari; Alina Genis; Konstantin Astafurov; Camilo Galeano; John Danias

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2454. doi:

ARVO Annual Meeting Abstract June 2015

Recreation of a 3-D Physiological Model of Conventional Outflow Tract in vitro

Karen Yud Torrejon; Cula Dautriche; Ellen Papke; W Daniel Stamer; John Danias; Magnus Bergkvist; Susan T Sharfstein; Yubing Xie

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3544. doi:

ARVO Annual Meeting Abstract June 2015

Oral microbiome alterations in glaucoma

Konstantin Astafurov; Daniel Polla; Leslie Hyman; Anne Griffen; Christina Igboin; John Danias

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3651. doi:

ARVO Annual Meeting Abstract June 2015

Dental Health in Glaucoma

Daniel Polla; Konstantin Astafurov; Eman Elhawy; Leslie Hyman; John Danias

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3715. doi:

ARVO Annual Meeting Abstract April 2014

C1q ablation protects Retinal Ganglion Cells in glaucoma.

Ruma Kumari; Alina Genis; Konstantin Astafurov; Hai M Tang; John Danias

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2432. doi:

ARVO Annual Meeting Abstract April 2014

The Use of Tissue Plasminogen Activator to Reduce Elevated Intraocular Pressure Induced by Prednisolone in Sheep.

Oscar A Candia; Rosana Gerometta; John Danias

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2884. doi:

ARVO Annual Meeting Abstract April 2014

Bioengineered 3D HTM is physiologically responsive to glucocorticoid

Karen Yud Torrejon; Adam Goodcoff; Cula Dautriche; Magnus Bergkvist; Yubing Xie; Susan Sharfstein; John Danias

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5654. doi:

ARVO Annual Meeting Abstract April 2014

Decreased PLAT expression and PLAT Promoter Activity after Steroid Treatment

Alina Genis; Sandeep Kumar; John Danias

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5657. doi:

ARVO Annual Meeting Abstract April 2014

3D-Bio-engineering of the Conventional Outflow Tract for High Throughput Glaucoma Drug Screening

Cula Dautriche; Karen Yud Torrejon; Magnus Bergkvist; Yubing Xie; Susan Sharfstein; John Danias

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5659. doi:

Glaucoma December 2013

Reduction of Steroid-Induced Intraocular Pressure Elevation in Sheep by Tissue Plasminogen Activator

PDF

Rosana Gerometta; Sandeep Kumar; Shaily Shah; Larry Alvarez; Oscar Candia; John Danias
TAGS: alteplase, intraocular pressure, sheep, steroids, eye
Invest. Ophthalmol. Vis. Sci.. 2013; 54(13):7903-7909. doi: https://doi.org/10.1167/iovs.13-12801

ARVO Annual Meeting Abstract June 2013

Reduction by tissue plasminogen activator (tPA) of steroid-induced intraocular pressure (IOP) elevation in sheep

Oscar Candia; Rosana Gerometta; John Danias

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):769. doi:

ARVO Annual Meeting Abstract June 2013

Effect of anecortave acetate (AA) on outflow facility in a mouse model of steroid-induced glaucoma

Sandeep Kumar; Shaily Shah; Emily Deutsch; Hai Tang; John Danias

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):782. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Intraocular pressure, optic nerve appearance, and posterior pole pathology in a large cohort of free-ranging rhesus macaques

3D Human Trabecular Meshwork model as a potential tool for gene screening

Tissue plasminogen activator (tPA) in outflow facility regulation

Tissue plasminogen activator (tPA) rescues steroid-induced outflow facility reduction via non-enzymatic action

Investigations on the Role of the Fibrinolytic Pathway on Outflow Facility Regulation

Stem Cell-Derived Schlemm’s Canal-like Cells for in vitro Glaucoma Drug Screening

Human microvascular endothelial cells (HMVECs) assume Schlemm’s canal (HSC) cell characteristics after co-culture with human trabecular meshwork (HTM) cells and can be used to model conventional outflow

Association between periodontal disease and primary open angle glaucoma

Differential effects of C1q ablation on glaucomatous damage in the two sexes in DBA/2 mice.

Recreation of a 3-D Physiological Model of Conventional Outflow Tract in vitro

Oral microbiome alterations in glaucoma

Dental Health in Glaucoma

C1q ablation protects Retinal Ganglion Cells in glaucoma.

The Use of Tissue Plasminogen Activator to Reduce Elevated Intraocular Pressure Induced by Prednisolone in Sheep.

Bioengineered 3D HTM is physiologically responsive to glucocorticoid

Decreased PLAT expression and PLAT Promoter Activity after Steroid Treatment

3D-Bio-engineering of the Conventional Outflow Tract for High Throughput Glaucoma Drug Screening

Reduction of Steroid-Induced Intraocular Pressure Elevation in Sheep by Tissue Plasminogen Activator

Reduction by tissue plasminogen activator (tPA) of steroid-induced intraocular pressure (IOP) elevation in sheep

Effect of anecortave acetate (AA) on outflow facility in a mouse model of steroid-induced glaucoma

To View More...

You must be signed into an individual account to use this feature.